v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses        
Research and development $ 3,941,932 $ 14,337,753 $ 11,877,612 $ 21,535,010
General and administrative 3,869,371 3,906,172 8,608,057 8,468,477
Change in estimate for legal contingency 3,250,000 0 3,250,000 0
Total operating expenses 11,061,303 18,243,925 23,735,669 30,003,487
Operating loss (11,061,303) (18,243,925) (23,735,669) (30,003,487)
Other (income) expense        
Interest expense 3,299 0 5,498 0
Interest and other income, net (103,208) (533,090) (272,823) (1,191,333)
Gains from asset sales (178,200) (89,363) (178,200) (89,363)
Other expense 0 0 2,411 0
Total other (income) expense, net (278,109) (622,453) (443,114) (1,280,696)
Loss before income taxes (10,783,194) (17,621,472) (23,292,555) (28,722,791)
Provision for income taxes 3,400 3,400 3,400 5,400
Net loss $ (10,786,594) $ (17,624,872) $ (23,295,955) $ (28,728,191)
Loss per common share:        
Basic (in dollars per share) $ (0.27) $ (0.44) $ (0.59) $ (0.72)
Diluted (in dollars per share) $ (0.27) $ (0.44) $ (0.59) $ (0.72)
Weighted average shares of common stock outstanding used to compute loss per share:        
Basic (in shares) 39,694,243 39,659,266 39,687,418 39,655,597
Diluted (in shares) 39,694,243 39,659,266 39,687,418 39,655,597